Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)
Clinical trial NCT01460498 · COMPLETED
Trial details
- NCT number
- NCT01460498
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-08
- Primary completion
- 2019-08-07
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.